{"altmetric_id":5051277,"counts":{"readers":{"mendeley":1,"citeulike":0,"connotea":0},"total":{"posts_count":18},"news":{"unique_users_count":1,"unique_users":["alzforum"],"posts_count":2},"twitter":{"unique_users_count":12,"unique_users":["VDallolio","AFTDCure","SelinaWray","AutophagyPapers","B_A_Benitez","RNAi_papers","fly_papers","MltplSclppr","UAB_Alzheimers","jsonyoung","fibrorat","NeuroGen_papers"],"posts_count":15},"googleplus":{"unique_users_count":1,"unique_users":["Adriana Schmid"],"posts_count":1}},"selected_quotes":["Brand new study describes a novel approach to drug development in PSP and CBD. Read more here","Herskowitz lab: ROCK inhibitors clear tau: --","Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal\u2026"],"citation":{"abstract":"Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are neurodegenerative four-repeat tauopathies with no cure. Mitigating pathogenic tau levels is a rational strategy for tauopathy treatment, but therapeutic targets with clinically available drugs are lacking. Here, we report that protein levels of the Rho-associated protein kinases (ROCK1 and ROCK2), p70 S6 kinase (S6K), and mammalian target of rapamycin (mTOR) were increased in PSP and CBD brains. RNAi depletion of ROCK1 or ROCK2 reduced tau mRNA and protein level in human neuroblastoma cells. However, additional phenotypes were observed under ROCK2 knockdown, including decreased S6K and phosphorylated mTOR levels. Pharmacologic inhibition of Rho kinases in neurons diminished detergent-soluble and -insoluble tau through a combination of autophagy enhancement and tau mRNA reduction. Fasudil, a clinically approved ROCK inhibitor, suppressed rough eye phenotype and mitigated pathogenic tau levels by inducing autophagic pathways in a Drosophila model of tauopathy. Collectively, these findings highlight the Rho kinases as rational therapeutic targets to combat tau accumulation in PSP and CBD.\nStudies of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) suggest that mitigating pathogenic tau levels is a rational strategy for tauopathy treatment. In this report, the Rho-associated protein kinases (ROCK1 and ROCK2) are identified as novel drug targets for PSP and CBD. We show that elevated insoluble tau levels are associated with increased ROCK1 and ROCK2 in PSP and CBD brains, whereas experiments in cellular and animal models identify pharmacologic inhibition of ROCKs as a mechanism-based approach to reduce tau levels. Our study correlates bona fide changes in PSP and CBD brains with cellular models, identifies drug targets, and tests the therapeutic in vivo.","altmetric_jid":"4f6fa4f53cf058f610002e79","authors":["Erik G. Gentry","Benjamin W. Henderson","Andrew E. Arrant","Marla Gearing","Yangbo Feng","Nicole C. Riddle","Jeremy H. Herskowitz","Gentry, Erik G","Henderson, Benjamin W","Arrant, Andrew E","Gearing, Marla","Feng, Yangbo","Riddle, Nicole C","Herskowitz, Jeremy H"],"doi":"10.1523\/jneurosci.2336-15.2016","endpage":"1323","first_seen_on":"2016-01-27T20:31:44+00:00","funders":["niehs"],"issns":["1529-2401","0270-6474"],"issue":"4","journal":"Journal of Neuroscience","last_mentioned_on":1464922565,"links":["http:\/\/www.jneurosci.org\/content\/36\/4\/1316.short?rss=1","http:\/\/www.jneurosci.org\/content\/36\/4\/1316.abstract","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26818518?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26818518","http:\/\/www.jneurosci.org\/content\/36\/4\/1316.short?sid=fce4c5eb-fc78-4769-86ae-9c7fd69b0569.]","http:\/\/www.jneurosci.org\/content\/36\/4\/1316.short?sid=fce4c5eb-fc78-4769-...","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26818518?platform=hootsuite"],"pdf_url":"http:\/\/www.jneurosci.org\/content\/36\/4\/1316.full.pdf","pmid":"26818518","pubdate":"2016-01-27T00:00:00+00:00","publisher":"Society for Neuroscience","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"},{"name":"Psychology And Cognitive Sciences","scheme":"era"}],"scopus_subjects":["Life Sciences","Neuroscience"],"startpage":"1316","subjects":["neurology"],"title":"Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration.","type":"article","volume":"36","mendeley_url":"http:\/\/www.mendeley.com\/research\/rho-kinase-inhibition-therapeutic-progressive-supranuclear-palsy-corticobasal-degeneration-1"},"altmetric_score":{"score":17.85,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":17.85},"context_for_score":{"all":{"total_number_of_other_articles":7849747,"mean":6.6509658923939,"rank":431722,"this_scored_higher_than_pct":94,"this_scored_higher_than":7417340,"rank_type":"exact","sample_size":7849747,"percentile":94},"similar_age_3m":{"total_number_of_other_articles":328558,"mean":9.4114240755786,"rank":25273,"this_scored_higher_than_pct":92,"this_scored_higher_than":303254,"rank_type":"exact","sample_size":328558,"percentile":92},"this_journal":{"total_number_of_other_articles":12125,"mean":9.5926484658528,"rank":1322,"this_scored_higher_than_pct":89,"this_scored_higher_than":10801,"rank_type":"exact","sample_size":12125,"percentile":89},"similar_age_this_journal_3m":{"total_number_of_other_articles":307,"mean":17.26785620915,"rank":58,"this_scored_higher_than_pct":81,"this_scored_higher_than":249,"rank_type":"exact","sample_size":307,"percentile":81}}},"demographics":{"poster_types":{"member_of_the_public":10,"researcher":1,"science_communicator":1},"users":{"twitter":{"cohorts":{"Members of the public":10,"Scientists":1,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Researcher":1},"by_discipline":{"Chemistry":1}}},"geo":{"twitter":{"IT":1,"US":4,"GB":3}}},"posts":{"news":[{"title":"Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration.","url":"http:\/\/ct.moreover.com\/?a=25368405199&p=1pl&v=1&x=e1TGBAK-ei-EUis81CbpMQ","license":"public","citation_ids":[5051277],"posted_on":"2016-02-06T05:19:00+00:00","summary":"Gentry EG, Henderson BW, Arrant AE, Gearing M, Feng Y, Riddle NC, Herskowitz JH.","author":{"name":"Alzforum","url":"http:\/\/www.alzforum.org","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/355\/normal\/Screen_Shot_2015-04-08_at_12.16.09_1.png?1428491784"}},{"title":"ROCK\u2019n the Tau Pathway? | ALZFORUM","url":"http:\/\/ct.moreover.com\/?a=25407190572&p=1pl&v=1&x=gDvS79B4-L9dEvIl8TDyYw","license":"public","citation_ids":[5051277,5051277,5156248,5156249,1233185,1821061,5156250,5156251,5156252,1012265,2000682,3571009,4924116,5156253,5156254,5156255,5156256,5156257],"posted_on":"2016-02-09T15:22:37+00:00","summary":"09 Feb 2016 A kinase inhibitor that is an approved medication for people and improves memory in rats also promotes degradation of toxic tau in lab models, according to a paper in the January 27 Journal of Neuroscience.","author":{"name":"Alzforum","url":"http:\/\/www.alzforum.org","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/355\/normal\/Screen_Shot_2015-04-08_at_12.16.09_1.png?1428491784"}}],"twitter":[{"url":"http:\/\/twitter.com\/VDallolio\/statuses\/692444842434109443","license":"gnip","citation_ids":[5051277],"posted_on":"2016-01-27T20:31:30+00:00","author":{"name":"Villiam Dallolio","url":"http:\/\/pro-mev.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/653565522580242432\/8sdJ60gz_normal.png","description":"Neurochirurgo\u2026. E non solo\u2026","id_on_source":"VDallolio","tweeter_id":"3937556356","geo":{"lt":45.66667,"ln":9.5,"country":"IT"},"followers":38},"tweet_id":"692444842434109443"},{"url":"http:\/\/twitter.com\/AFTDCure\/statuses\/692759269255553024","license":"gnip","citation_ids":[5051277],"posted_on":"2016-01-28T17:20:55+00:00","author":{"name":"The AFTD","url":"http:\/\/www.theaftd.org","image":"https:\/\/pbs.twimg.com\/profile_images\/875386462556090368\/mZlIlw6k_normal.jpg","description":"We envision a world where FTD is understood, effectively diagnosed, treated, cured and ultimately prevented.","id_on_source":"AFTDCure","tweeter_id":"305591010","geo":{"lt":40.04622,"ln":-75.35991,"country":"US"},"followers":1080},"tweet_id":"692759269255553024"},{"url":"http:\/\/twitter.com\/SelinaWray\/statuses\/692762064302030848","license":"gnip","rt":["AFTDCure"],"citation_ids":[5051277],"posted_on":"2016-01-28T17:32:01+00:00","author":{"name":"Selina Wray","image":"https:\/\/pbs.twimg.com\/profile_images\/898173767695859713\/LhfUoKft_normal.jpg","description":"Alzheimer's Research UK Senior Research Fellow at UCL Institute of Neurology. @wraylabUCL","id_on_source":"SelinaWray","tweeter_id":"325755704","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":2078},"tweet_id":"692762064302030848"},{"url":"http:\/\/twitter.com\/AutophagyPapers\/statuses\/693026327637598208","license":"gnip","citation_ids":[5051277],"posted_on":"2016-01-29T11:02:06+00:00","author":{"name":"Autophagy Papers","image":"https:\/\/pbs.twimg.com\/profile_images\/559405603697590273\/EoGNUIXe_normal.jpeg","description":"Twitterbot for #Autophagy papers. Curated by @SoniaHall","id_on_source":"AutophagyPapers","tweeter_id":"2996105102","geo":{"lt":null,"ln":null},"followers":354},"tweet_id":"693026327637598208"},{"url":"http:\/\/twitter.com\/B_A_Benitez\/statuses\/693029108863803392","license":"gnip","citation_ids":[5051277],"posted_on":"2016-01-29T11:13:10+00:00","author":{"name":"Bruno A. Benitez, MD","url":"https:\/\/scholar.google.com\/citations?user=oKv9jsUAAAAJ&hl=en","image":"https:\/\/pbs.twimg.com\/profile_images\/444707176045494272\/Tm3TcWsr_normal.jpeg","description":"Instructor in Medicine @WUSTL #Genomics #Alzheimers, #Parkinsons, #Lysosomal storage disorders, #raredisease #rarevariants #openaccess","id_on_source":"B_A_Benitez","tweeter_id":"2411535075","geo":{"lt":38.62727,"ln":-90.19789,"country":"US"},"followers":224},"tweet_id":"693029108863803392"},{"url":"http:\/\/twitter.com\/RNAi_papers\/statuses\/693030853127966720","license":"gnip","citation_ids":[5051277],"posted_on":"2016-01-29T11:20:05+00:00","author":{"name":"RNAi papers","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","description":"Twitter bot searching the web for new journal articles on #RNAi therapeutics for plants and animals","id_on_source":"RNAi_papers","tweeter_id":"2902044872","geo":{"lt":54.58333,"ln":-5.93333,"country":"GB"},"followers":46},"tweet_id":"693030853127966720"},{"url":"http:\/\/twitter.com\/fly_papers\/statuses\/693040374298730496","license":"gnip","citation_ids":[5051277],"posted_on":"2016-01-29T11:57:55+00:00","author":{"name":"flypapers","image":"https:\/\/pbs.twimg.com\/profile_images\/3298285242\/dc1d0402d707fe3606f9d653cd85fe6d_normal.jpeg","description":"Twitterbot of #Drosophila papers in #PubMed\/#arXiv\/#bioRxiv\/#PeerJ\/#F1000. Curated by @caseybergman. Image credit: http:\/\/en.wikipedia.org\/wiki\/Drosophila_hydei","id_on_source":"fly_papers","tweeter_id":"1213590199","geo":{"lt":null,"ln":null},"followers":1972},"tweet_id":"693040374298730496"},{"url":"http:\/\/twitter.com\/MltplSclppr\/statuses\/693064594902818816","license":"gnip","citation_ids":[5051277],"posted_on":"2016-01-29T13:34:10+00:00","author":{"name":"MS Papers","image":"https:\/\/pbs.twimg.com\/profile_images\/599614030790008833\/7IuEjHC7_normal.jpg","id_on_source":"MltplSclppr","tweeter_id":"3262004991","geo":{"lt":null,"ln":null},"followers":212},"tweet_id":"693064594902818816"},{"url":"http:\/\/twitter.com\/UAB_Alzheimers\/statuses\/694556111073103873","license":"gnip","citation_ids":[5051277],"posted_on":"2016-02-02T16:20:55+00:00","author":{"name":"UAB Alzheimer Center","url":"http:\/\/www.uab.edu\/alzheimers","image":"https:\/\/pbs.twimg.com\/profile_images\/610479938471264259\/_HBP7_rj_normal.jpg","description":"The UAB Alzheimer's Disease Center is dedicated to overcoming Alzheimer's disease and related disorders through research, patient care, and education.","id_on_source":"UAB_Alzheimers","tweeter_id":"3028404046","geo":{"lt":33.52066,"ln":-86.80249,"country":"US"},"followers":169},"tweet_id":"694556111073103873"},{"url":"http:\/\/twitter.com\/UAB_Alzheimers\/statuses\/699675991690633216","license":"gnip","citation_ids":[5051277],"posted_on":"2016-02-16T19:25:30+00:00","author":{"name":"UAB Alzheimer Center","url":"http:\/\/www.uab.edu\/alzheimers","image":"https:\/\/pbs.twimg.com\/profile_images\/610479938471264259\/_HBP7_rj_normal.jpg","description":"The UAB Alzheimer's Disease Center is dedicated to overcoming Alzheimer's disease and related disorders through research, patient care, and education.","id_on_source":"UAB_Alzheimers","tweeter_id":"3028404046","geo":{"lt":33.52066,"ln":-86.80249,"country":"US"},"followers":169},"tweet_id":"699675991690633216"},{"url":"http:\/\/twitter.com\/jsonyoung\/statuses\/699676658446557184","license":"gnip","rt":["UAB_Alzheimers"],"citation_ids":[5051277],"posted_on":"2016-02-16T19:28:09+00:00","author":{"name":"Jason Young","url":"http:\/\/www.linkedin.com\/in\/jsonyoung\/","image":"https:\/\/pbs.twimg.com\/profile_images\/866393007108628481\/kZC-rk9E_normal.jpg","description":"Director of Programs & Public Policy w\/ the Alzheimer's Association, AL\/FL Panhandle Chapter","id_on_source":"jsonyoung","tweeter_id":"14563894","geo":{"lt":33.52066,"ln":-86.80249,"country":"US"},"followers":2413},"tweet_id":"699676658446557184"},{"url":"http:\/\/twitter.com\/fibrorat\/statuses\/701575256658432000","license":"gnip","rt":["AFTDCure"],"citation_ids":[5051277],"posted_on":"2016-02-22T01:12:30+00:00","author":{"name":"steph mclain","image":"https:\/\/pbs.twimg.com\/profile_images\/606922652909891585\/sbkg1MYW_normal.jpg","id_on_source":"fibrorat","tweeter_id":"942637808","geo":{"lt":null,"ln":null},"followers":371},"tweet_id":"701575256658432000"},{"url":"http:\/\/twitter.com\/RNAi_papers\/statuses\/738312600312647680","license":"gnip","citation_ids":[5051277],"posted_on":"2016-06-02T10:13:35+00:00","author":{"name":"RNAi papers","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","description":"Twitter bot searching the web for new journal articles on #RNAi therapeutics for plants and animals","id_on_source":"RNAi_papers","tweeter_id":"2902044872","geo":{"lt":54.58333,"ln":-5.93333,"country":"GB"},"followers":46},"tweet_id":"738312600312647680"},{"url":"http:\/\/twitter.com\/MltplSclppr\/statuses\/738336265590870016","license":"gnip","citation_ids":[5051277],"posted_on":"2016-06-02T11:47:37+00:00","author":{"name":"MS Papers","image":"https:\/\/pbs.twimg.com\/profile_images\/599614030790008833\/7IuEjHC7_normal.jpg","id_on_source":"MltplSclppr","tweeter_id":"3262004991","geo":{"lt":null,"ln":null},"followers":212},"tweet_id":"738336265590870016"},{"url":"http:\/\/twitter.com\/NeuroGen_papers\/statuses\/738564884607033344","license":"gnip","citation_ids":[5051277],"posted_on":"2016-06-03T02:56:05+00:00","author":{"name":"NeuroGenetics papers","url":"http:\/\/neurogeneticslab.wordpress.com","image":"https:\/\/pbs.twimg.com\/profile_images\/508573077727223808\/P7-OnZSA_normal.png","description":"Twitterbot from @TheGBLab! Follow me to stay up to date with research in #Alzheimer's, #Parkinson's & #Neurogenetics in general. Also on http:\/\/goo.gl\/BNgYFd","id_on_source":"NeuroGen_papers","tweeter_id":"2795689592","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":693},"tweet_id":"738564884607033344"}],"googleplus":[{"url":"https:\/\/plus.google.com\/104131646184516901798\/posts\/dUB7WJLqjdZ","license":"public","citation_ids":[5051277],"posted_on":"2016-02-08T08:45:11+00:00","summary":"Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration. - PubMed - NCBI J Neurosci. 2016 Jan 27;36(4):1316-23. doi: 10.1523\/JNEUROSCI.2336-15.2016. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26818518","author":{"name":"Adriana Schmid","url":"https:\/\/plus.google.com\/104131646184516901798","image":"https:\/\/lh6.googleusercontent.com\/-hHfY6zhvwwo\/AAAAAAAAAAI\/AAAAAAAAAWg\/kewwnPxP-Jw\/photo.jpg?sz=50","id_on_source":"104131646184516901798"}}]}}